News
14.01.14
From Telethon-funded gene therapy comes a new weapon in the battle against cancer
The innovative technique developed in the laboratories of the Telethon San Raffaele Institute for Gene Therapy for the treatment of two extremely serious genetic diseases can also be effective in treating tumours.
14.01.14
TIGEM: a centre of excellence for the south
The new premises of the Telethon Institute for Genetics and Medicine (Tigem) is set to open in the former "Olivetti area" in Pozzuoli.
06.11.13
Research into a rare kidney disease reveals a mechanism responsible for hypertension
Research into a rare kidney disease has shed important light on a possible way to tackle high blood pressure, a risk factor for the circulatory system that in Italy alone affects a third of the adult population.
29.10.13
Polycystic kidney: a problem of tubule expansion lies at the base of polycystic kidney disease
New light has been shed on the molecular mechanisms that lie at the base of one of the most common genetic diseases, autosomal dominant polycystic kidney, which in Italy alone affects 60 thousand people.
16.10.13
Collaboration agreement between Telethon Foundation and Rare Partners
Telethon has renewed the agreement with Rare Partners for the development of diagnostic tools and therapeutic approaches based on the results of research projects funded by the Telethon Foundation.
04.10.13
Possible culprits in congenital heart defects identified
Researchers at Washington University School of Medicine in St. Louis and the University of Padua-Dulbecco Telethon Institute in Italy have shown that mitochondria remarkably also orchestrate events that determine a cell's future, at least in the embryonic mouse heart
04.10.13
New "muscle-saver" molecular strategy discovered
A new molecular strategy is described for enhancement of muscle growth and for consequent containment of the adverse effects of degenerative diseases such as muscular dystrophy and atrophy
24.09.13
Research: correlation discovered between neurological deficits and ferritin deficiency
A study conducted by researchers at IRCCS Ospedale San Raffaele Milano, funded by Telethon and coordinated by Prof. Sonia Levi was published in The Journal of Experimental Medicine.
20.09.13
Mitochondrial diseases: here's the metabolism-helper gene
A case of malfunctioning mitochondria? Considerable help may be provided by OPA1 – a gene which, when altered, is known to be responsible for a hereditary disease of the eye, dominant optic atrophy.
